Recent 13F filings as of December 2025 show that 114 institutional investors hold a position in Cytek Biosciences, Inc. (NASDAQ:CTKB).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 17,173,028 | 625,335 | 3.78% | $86,723,792.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 7,475,477 | 541,973 | 7.82% | $37,751,160.00 |
| Boston Partners | 31 Dec, 2025 | 5,008,309 | 4,971,126 | 13,369.35% | $25,297,227.00 |
| STATE STREET CORP | 31 Dec, 2025 | 4,146,964 | 62,596 | 1.53% | $20,942,168.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 2,790,574 | 7,125 | 0.26% | $14,095,696.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 2,646,891 | -570,897 | -17.74% | $13,366,732.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 1,789,914 | 52,605 | 3.03% | $9,039,066.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 1,700,985 | 237,844 | 16.26% | $8,589,975.00 |
| ROYCE & ASSOCIATES LP | 31 Dec, 2025 | 1,692,657 | -70,605 | -4.00% | $8,547,918.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 1,094,539 | -10,482 | -0.95% | $5,527,422.00 |
| RENAISSANCE TECHNOLOGIES LLC | 31 Dec, 2025 | 675,000 | -120,544 | -15.15% | $3,408,750.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 674,475 | 108,902 | 19.26% | $3,402.00 |
| PRINCIPAL FINANCIAL GROUP INC | 31 Dec, 2025 | 666,927 | 43,621 | 7.00% | $3,367,982.00 |
| Bank of New York Mellon Corp | 31 Dec, 2025 | 637,929 | -35,640 | -5.29% | $3,221,542.00 |
| UBS Group AG | 31 Dec, 2025 | 460,047 | -8,642 | -1.84% | $2,323,238.00 |
| HRT FINANCIAL LP | 31 Dec, 2025 | 437,653 | 437,653 | 0.00% | $2,210.00 |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 31 Dec, 2025 | 379,274 | -47,532 | -11.14% | $1,915,334.00 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 31 Dec, 2025 | 361,677 | 387 | 0.11% | $1,826,469.00 |
| JPMORGAN CHASE & CO | 31 Dec, 2025 | 328,853 | -29,870 | -8.33% | $1,660,708.00 |
| Simcoe Capital LLC | 31 Dec, 2025 | 298,461 | 298,461 | 0.00% | $1,507,228.00 |